BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9716603)

  • 1. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.
    Reiter A; Sohal J; Kulkarni S; Chase A; Macdonald DH; Aguiar RC; Gonçalves C; Hernandez JM; Jennings BA; Goldman JM; Cross NC
    Blood; 1998 Sep; 92(5):1735-42. PubMed ID: 9716603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.
    Kulkarni S; Reiter A; Smedley D; Goldman JM; Cross NC
    Genomics; 1999 Jan; 55(1):118-21. PubMed ID: 9889006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
    Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
    Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of four new translocations involving FGFR1 in myeloid disorders.
    Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
    Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
    Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].
    Zhou F; Chen S; Chao H; Zhang R; Zhou M; Pan J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):291-6. PubMed ID: 25916288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.
    Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M
    Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.
    Demiroglu A; Steer EJ; Heath C; Taylor K; Bentley M; Allen SL; Koduru P; Brody JP; Hawson G; Rodwell R; Doody ML; Carnicero F; Reiter A; Goldman JM; Melo JV; Cross NC
    Blood; 2001 Dec; 98(13):3778-83. PubMed ID: 11739186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
    Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1.
    Popovici C; Zhang B; Grégoire MJ; Jonveaux P; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Blood; 1999 Feb; 93(4):1381-9. PubMed ID: 9949182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Grand EK; Grand FH; Chase AJ; Ross FM; Corcoran MM; Oscier DG; Cross NC
    Genes Chromosomes Cancer; 2004 May; 40(1):78-83. PubMed ID: 15034873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
    Kulkarni S; Heath C; Parker S; Chase A; Iqbal S; Pocock CF; Kaeda J; Cwynarski K; Goldman JM; Cross NC
    Cancer Res; 2000 Jul; 60(13):3592-8. PubMed ID: 10910073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome.
    Li F; Zhai YP; Tang YM; Wang LP; Wan PJ
    Genes Chromosomes Cancer; 2012 Sep; 51(9):890-7. PubMed ID: 22619110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).
    Popovici C; Adélaïde J; Ollendorff V; Chaffanet M; Guasch G; Jacrot M; Leroux D; Birnbaum D; Pébusque MJ
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5712-7. PubMed ID: 9576949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
    Aguiar RC; Chase A; Coulthard S; Macdonald DH; Carapeti M; Reiter A; Sohal J; Lennard A; Goldman JM; Cross NC
    Blood; 1997 Oct; 90(8):3130-5. PubMed ID: 9376594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the breakpoints in a t(8;13)(p11;q12) translocation from a patient with myeloproliferative disease using fluorescence in situ hybridization.
    Chernova O; Still I; Kalaycio M; Hoeltge G; Cowell JK
    Genes Chromosomes Cancer; 1998 Feb; 21(2):160-5. PubMed ID: 9491328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
    Macdonald D; Reiter A; Cross NC
    Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
    Dong S; Kang S; Gu TL; Kardar S; Fu H; Lonial S; Khoury HJ; Khuri F; Chen J
    Blood; 2007 Jul; 110(1):360-9. PubMed ID: 17389761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.